Hypoxia in tumors: molecular targets for anti-cancer therapeutics

Adv Enzyme Regul. 2004;44:93-108. doi: 10.1016/j.advenzreg.2003.11.019.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Cell Line, Tumor
  • DNA-Binding Proteins / physiology
  • Drug Design
  • Humans
  • Hypoxia / physiopathology*
  • Hypoxia-Inducible Factor 1
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Mice
  • Mice, Nude
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Neoplasms / physiopathology
  • Nuclear Proteins / physiology
  • Transcription Factors / physiology
  • Transplantation, Heterologous

Substances

  • Antineoplastic Agents
  • DNA-Binding Proteins
  • HIF1A protein, human
  • Hif1a protein, mouse
  • Hypoxia-Inducible Factor 1
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Nuclear Proteins
  • Transcription Factors